Serum salusin-β levels in patients with systemic lupus erythematosus.

Mehrzad HajialiloRazieh JorjaniMehran RahimiAmir GhorbanihaghjoAida Malek MahdaviMorteza GhojazadehAlireza Khabbazi

Published in: Clinical rheumatology (2023)

Our findings showed that salusin-β might have a possible role in the pathogenesis of SLE. Salusin-β may be a potential biomarker for nephritis and thrombosis in SLE. Key Points • Serum salusin-β levels were significantly higher in SLE patients than the control group. • There was no significant correlation between serum salusin-β levels with age and SLEDAI. • Serum salusin-β levels retained a significant association with nephritis and thrombosis.

Keyphrases

systemic lupus erythematosus
end stage renal disease
disease activity
pulmonary embolism
chronic kidney disease
rheumatoid arthritis
prognostic factors
peritoneal dialysis
patient reported outcomes